Dergiler / Medicine Science / 2019 / Cilt: 8 - Sayı: 1

Objective and subjective cure rates of Ophira mini sling: Postoperative 36-month results

Sayfa
154–157
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Ophira mini sling could be good option for treating female SUI with high objective and subjective cure rates and no major complications.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:This study aimed to evaluate the objective and subjective cure rates of Ophira mini sling for female stress urinary incontinence (SUI) 36 months after surgery.
📊
Temel Bulgular & Veri:A total of 58 patients who had SUI and were treated with Ophira mini sling between the years 2014 and 2015 were evaluated retrospectively.
💡
Sonuç & Katkı:Ophira mini sling could be good option for treating female SUI with high objective and subjective cure rates and no major complications.
🔬Tür:Uygulamalı Anket & Alan Araştırması
📍Kapsam:2014 Verileri
⚙️Değişkenler:Alan Parametreleri

Özet

This study aimed to evaluate the objective and subjective cure rates of Ophira mini sling for female stress urinary incontinence (SUI) 36 months after surgery. A total of 58 patients who had SUI and were treated with Ophira mini sling between the years 2014 and 2015 were evaluated retrospectively. The objective cure rate was estimated with the negative cough stress test, and the subjective cure rate was estimated with the answer of “no leakage on coughing, sneezing” to question 3 in urinary distress inventory-6 (UDI-6). Incontinence impact questionnaire-7 (IIQ-7) and pelvic distress inventory-20 (PFDI-20) were also evaluated 36 months after surgery. The overall subjective cure rate was 90% (36/40), and the overall objective cure rate was 87.5% (35/40). The UDI-6, IIQ-7, and PFDI-20 scores improved significantly (P ˂ 0.001). No major complications were noted. Ophira mini sling could be good option for treating female SUI with high objective and subjective cure rates and no major complications.

🔖

Bu Makaleye Atıf Yap

KÖLELİ, I. (2019). Objective and subjective cure rates of Ophira mini sling: Postoperative 36-month results. Medicine Science, Cilt: 8 - Sayı: 1, 154–157. https://ajindex.com/articles/276928

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

  1. Ford AA, Rogerson L, Cody JD, et al. Mid-urethral sling operations for stress urinary incontinence in women. Cochrane database Syst Rev. 2015;7:6375. Nitti VW. The prevalence of urinary incontinence. Rev Urol. 2001;3:2-6.
  2. Ulmsten U, Petros P. Intravaginal slingplasty (IVS): an ambulatory surgical procedure for treatment of female urinary incontinence. Scand J Urol Nephrol. 1995;29:75-82.
  3. Ogah J, Cody DJ, Rogerson L. Minimally invasive synthetic suburethral sling operations for stress urinary incontinence in women: a short version Cochrane review. Neurourol Urodyn. 2011;30:284-91.
  4. Ford AA, Rogerson L, Cody JD, et al. Mid-urethral sling operations for stress urinary incontinence in women. Cochrane Database Syst Rev. 2017;7:6375 Cadish LA, Hacker MR, Modest AM, et al. Characterization of pain after inside-out transobturator midurethral sling. Female Pelvic Med Reconstr Surg. 2014;20:99-103.
  5. Thomas TN, Siff LS, Jelovsek JE, et al. Surgical Pain After Transobturator and Retropubic Midurethral Sling Placement. Obstet Gynecol Surv. 2017:72;594-5.
  6. Cam C, Sakalli M, Ay P, et al. Validation of the Short Forms of the Incontinence Impact Questionnaire (IIQ-7) and the Urogenital Distress Inventory (UDI-6) in a Turkish Population. Neurourol Urodyn. 2007;26:129-33.
  7. Celenay ST, Akbayrak T, Kaya S, et al. Validity and reliability of the Turkish version of the Pelvic Floor Distress Inventory-20. Int. Urogynecol J. 2012;23:1123-27.
  8. Kim A, Kim MS, Park YJ, et al. An updated systematic review and metaanalysis: Clinical outcome of single-incision slings excluding TVT-Secur versus standard slings in surgical management of stress incontinence. BJU Int. 2018.
  9. Epub ahead of print Palma P, Riccetto C, Castro R, et al. Safety and efficacy of the ophira minisling system: One year follow-up from a multicenter international clinical trial. UroToday Int J. 2011;4:44. Sharifiaghdas F, Nasiri M, Mirzaei M, et al. Mini Sling (Ophira) versus pubovaginal sling for treatment of stress urinary incontinence: A mediumterm follow-up. Prague Med. Rep. 2015;116:210-8.
  10. Smith PP, Dhillon RK, M. Baptiste AS, Arunkalaivanan. Comparison of singleincision mid-urethral tape (OphiraTM) and transobturator tape (ObtryxTM) sub-urethral sling procedures for female stress urinary incontinence. J Clin Med Res. 2013;5:53-7.
  11. Yildiz G, Ceylan Y, Ucer O, et al. Safety and efficacy of single-incision sling for female stress urinary incontinence: 3 years’ results. Int Urogynecol J. 2016;27:1667-71.
  12. Taner CE, Okay G, Gö